TempraMed developed patent protected technology that can be used in a wide range of Medical/Consumer products, providing temperature control without need for power source or human intervention for years and additionally track medication use.

TempraMed already sells products to the first vertical, addressing the need to provide temperature control and management to temperature sensitive injectable medications such as Insulin, EpiPen, Biologics, Hormones…, to patients worldwide – a growing market opportunity.

We already have two devices on the market one is for insulin & Ozempic and the second is for EpiPen. Our products have been very successful to date (about 80,000 sold 4.8/5 customer rating).

TempraMed’ s product addresses the need of patients, HCP, and payors to make sure medications are tracked and controlled to maintain their potency.

While initial target customers for the products are the patients as the products become the standard, they will be adopted by the payors and pharmaceutical companies.

The technology we use allow our products to be very small and lightweight while they::• Work 24/7/365 for years.• Do not require batteries or charging of any kind for it to maintain proper temperature.• Are hassle and fuss free, and simple to use.As consumer medical products they require FDA registration (510K exempt) and medical device ISO certification in the USA, while in other countries they are considered consumer products.

Therefore, the company was able to use D2C online sales channels, parallel to selling the product to B2B customersOur smart thermal shield combines a unique ultrahigh vacuum thermal insulation and a small amount of heat absorbing phase change material and uses our unique thermal design.

This combination blocks and absorbs heat during the entire day time, and releases the absorbed heat back to the environment overnight, regaining its heat absorbing capacity for the following day, without any intervention.